Efficacy and safety of Lacticaseibacillus paracasei Lpc-37® in students facing examination stress: A randomized, triple-blind, placebo-controlled clinical trial (the ChillEx study).
- 2023-10
- RCT
- Brain, behavior, & immunity - health 32
- Sanna M Mäkelä
- Síle M Griffin
- Jenni Reimari
- Kara C Evans
- Ashley A Hibberd
- Nicolas Yeung
- Alvin Ibarra
- Jouni Junnila
- Jari Turunen
- Ronnie Beboso
- Balgit Chhokar
- Timothy G Dinan
- John Cryan
- Elaine Patterson
- PubMed: 37662485
- DOI: 10.1016/j.bbih.2023.100673
- High evidence
There was no difference between Lpc-37 and placebo groups in the change of STAI-state score (estimate 1.03; 95% confidence interval [CI]: -1.62, 3.67; p = 0.446).
- Effect
- Neutral
- Effect size
- Small
- Significant
- No